Delivery Order SPE2DB24D9113-SPE2DB25FEQDX
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12,057.76 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 133 mg/10 mL vials. This firm fixed-price delivery order, issued on September 9, 2025, with an ultimate completion date of September 30, 2025, represents a continuation of the agency's pharmaceutical supply chain operations without set-aside designation. The award leverages...
- The Defense Logistics Agency awarded a delivery order valued at $7,531.89 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. This firm fixed-price delivery order, awarded on September 12, 2025, with an ultimate completion date of October 3, 2025, represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The contract involves no...
- The Defense Logistics Agency awarded a delivery order valued at $12,553.15 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. This firm fixed-price delivery order, awarded on June 2, 2025, with completion targeted for June 24, 2025, represents a direct pharmaceutical supply requirement for federal healthcare operations. The award carries no set-aside designation, demonstrating...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,042.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. This firm fixed-price delivery order, awarded on September 19, 2025, with an ultimate completion date of October 10, 2025, represents a direct pharmaceutical supply fulfillment to support Department of Defense medical facilities. The award carries no...
- The Defense Logistics Agency awarded a delivery order valued at $15,063.78 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 mL vials. This firm fixed-price delivery order, issued on July 30, 2025, with an ultimate completion date of August 20, 2025, represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The contract carries no...
- The Defense Logistics Agency awarded a $6,028.88 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 133 mg/10 ml vials. The award, issued on September 19, 2025, with an ultimate completion date of October 10, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 mL vials. The contract, awarded on September 26, 2025, carries a ceiling value of approximately $30,128 and is structured as a firm fixed-price delivery order with an ultimate completion date of October 20, 2025. This award was made without a set-aside designation, allowing the vendor to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,145.70 contract is for the supply of EXPAREL 133 MG/10 ML VIAL 10ML, a pharmaceutical product, to support the recurring medical supply needs of military health facilities. This delivery order is placed under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. The contract, awarded on September 24, 2025, carries a ceiling value of $15,063.78 and is structured as a firm fixed-price delivery order with an ultimate completion date of October 16, 2025. This award utilizes no set-aside designation, demonstrating the vendor's competitive...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,855.64 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of EXPAREL 133 MG/10 ML VIAL 10ML, a pharmaceutical product. This delivery order contract is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB...
- SPE2DB24D9113Indefinite Delivery Contract
- SPE2DB24D9113-SPE2DB25FEQDXDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,536.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 133 mg/10 mL vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of October 15, 2025, and was awarded on September 23, 2025. No set-aside designation was utilized for this award, indicating the vendor competed on an unrestricted basis. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency, a single-award vehicle valued at approximately $500 million and valid through November 2026. The IDC enables the Defense Logistics Agency to procure pharmaceutical products and medical supplies to support Department of Defense healthcare systems and military medical facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently delivering a comprehensive range of branded and generic prescription medications, biologics, and medical consumables to defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 9/23/25 |